News/ News/ News/ Oncology/ R&D Roche’s oral SERD giredestrant fails breast cancer trial Phil Taylor amcenestrant, breast cancer, elacestant, Giredestrant, Menarini Group, Oncology, Radius Health, Roche, Sanofi, serd 0 Comment Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial Share X Roche’s oral SERD giredestrant fails breast cancer trial https://pharmaphorum.com/news/roches-oral-serd-giredestrant-fails-breast-cancer-trial/